Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRKAR1AP1 is classified as a pseudogene—a segment of DNA resembling a gene, but incapable of producing a functional protein product[3][6][8]. It shares high sequence similarity with the functional gene PRKAR1A, which encodes the regulatory subunit type I-alpha of cAMP-dependent protein kinase (Protein Kinase A)[1][7]. However, unlike PRKAR1A, PRKAR1AP1 does not code for a functional protein and lacks a defined biological function or therapeutic application[3][6][8]. Pseudogenes such as PRKAR1AP1 may arise through gene duplication or retrotransposition events but acquire mutations that disrupt protein-coding capacity[6][8]. PRKAR1AP1 should not be considered a drug target, biomarker, or entity with disease association or pharmacological relevance[3][6][8]. This target contains “pseudogene” in its canonical name, and database entries confirm it encodes no protein (amino acid length: 0)[3][6][8]. The functional, clinically relevant gene is PRKAR1A, not PRKAR1AP1[1][7]. No drugs, biomarkers, biological functions, or disease roles are known for PRKAR1AP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on protein kinase cAMP-dependent type I regulatory subunit alpha pseudogene 1 (PRKAR1AP1).